Monoclonal Gammopathy of Undetermined Significance
"Monoclonal Gammopathy of Undetermined Significance" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Conditions characterized by the presence of M protein (Monoclonal protein) in serum or urine without clinical manifestations of plasma cell dyscrasia.
MeSH Number(s)
C15.378.147.542.640
C20.683.460.640
C20.683.780.640
Concept/Terms
Monoclonal Gammopathy of Undetermined Significance- Monoclonal Gammopathy of Undetermined Significance
- Monoclonal Gammapathies, Benign
- Benign Monoclonal Gammapathies
- Benign Monoclonal Gammapathy
- Gammapathies, Benign Monoclonal
- Gammapathy, Benign Monoclonal
- Monoclonal Gammapathy, Benign
- Monoclonal Gammopathies, Benign
- Benign Monoclonal Gammopathies
- Benign Monoclonal Gammopathy
- Gammopathies, Benign Monoclonal
- Gammopathy, Benign Monoclonal
- Monoclonal Gammopathy, Benign
- Monoclonal Gammapathy of Undetermined Significance
Below are MeSH descriptors whose meaning is more general than "Monoclonal Gammopathy of Undetermined Significance".
Below are MeSH descriptors whose meaning is more specific than "Monoclonal Gammopathy of Undetermined Significance".
This graph shows the total number of publications written about "Monoclonal Gammopathy of Undetermined Significance" by people in Harvard Catalyst Profiles by year, and whether "Monoclonal Gammopathy of Undetermined Significance" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 0 | 1 |
| 2000 | 1 | 0 | 1 |
| 2005 | 0 | 1 | 1 |
| 2010 | 3 | 1 | 4 |
| 2011 | 4 | 0 | 4 |
| 2012 | 2 | 0 | 2 |
| 2013 | 2 | 1 | 3 |
| 2014 | 2 | 3 | 5 |
| 2015 | 4 | 3 | 7 |
| 2016 | 5 | 1 | 6 |
| 2017 | 2 | 2 | 4 |
| 2018 | 6 | 1 | 7 |
| 2019 | 7 | 1 | 8 |
| 2020 | 3 | 0 | 3 |
| 2021 | 2 | 1 | 3 |
| 2022 | 9 | 0 | 9 |
| 2023 | 8 | 0 | 8 |
| 2024 | 1 | 0 | 1 |
Below are the most recent publications written about "Monoclonal Gammopathy of Undetermined Significance" by people in Profiles.
-
Mass spectrometry-detected MGUS is associated with obesity and other novel modifiable risk factors in a high-risk population. Blood Adv. 2024 Apr 09; 8(7):1737-1746.
-
It is worth the weight: obesity and the transition from monoclonal gammopathy of undetermined significance to multiple myeloma. Blood Adv. 2023 09 26; 7(18):5510-5523.
-
Disentangling age, gender, and racial/ethnic disparities in multiple myeloma burden: a modeling study. Nat Commun. 2023 09 20; 14(1):5768.
-
Natural Language Processing-Assisted Classification Models to Confirm Monoclonal Gammopathy of Undetermined Significance and Progression in Veterans' Electronic Health Records. JCO Clin Cancer Inform. 2023 Sep; 7:e2300081.
-
Mortality in the US Populations With Monoclonal Gammopathy of Undetermined Significance. JAMA Oncol. 2023 09 01; 9(9):1293-1295.
-
Monoclonal B-cell lymphocytosis, monoclonal gammopathy of undetermined significance, and T-cell clones of uncertain significance: are these premalignant conditions sharing a common identity? Lancet Haematol. 2023 Jul; 10(7):e549-e556.
-
Updates in Plasma Cell Dyscrasias and Related Monoclonal Immunoglobulin-Mediated Renal Disease. Semin Nephrol. 2022 11; 42(6):151352.
-
Monoclonal gammopathy of thrombotic/thrombocytopenic significance. Blood. 2023 04 06; 141(14):1772-1776.
-
Personalised progression prediction in patients with monoclonal gammopathy of undetermined significance or smouldering multiple myeloma (PANGEA): a retrospective, multicohort study. Lancet Haematol. 2023 Mar; 10(3):e203-e212.
-
The promise and harms of screening for plasma cell dyscrasias. Br J Haematol. 2023 03; 200(6):704-707.